Divis Laboratories Ltd | DIVI - Sales Revenues

Stock Price
6,685.50
Daily Change
-75.00 -1.11%
Monthly
6.46%
Yearly
1.60%
Q2 Forecast
6,615.83

Divis Laboratories Ltd reported INR26.04B in Sales Revenues for its fiscal quarter ending in December of 2025.





Sales Change Date
Alaunos Therapeutics USD 2K 2K Mar/2025
Aurobindo Pharma INR 86.46B 3.6B Dec/2025
Avita Medical AUD 17.61M 805K Dec/2025
Dianthus Therapeutics USD 284K 112K Dec/2025
Divis Laboratories Ltd INR 26.04B 1.11B Dec/2025
Ionis Pharmaceuticals USD 246M 43M Mar/2026
IQVIA Holdings USD 4.15B 210M Mar/2026
Lupin INR 74.75B 3.41B Mar/2026
Moderna USD 389M 289M Mar/2026
Organon & Co USD 1.46B 50M Mar/2026
Revvity USD 711M 61.06M Mar/2026
Tectonic Therapeutic USD 0 0 Dec/2024
Tilray USD 217.51M 74.75M Dec/2025
Viatris USD 3.52B 180M Mar/2026
Xeris Pharmaceuticals USD 83.13M 2.68M Mar/2026